Enliven Therapeutics (ELVN) Fair Value & DCF
ELVN$48.80+0.49 +1.01%
Market cap$3.59BEnterprise value$3.62BRevenue (TTM)$0Market position—
Score
68
Bullish
Value
58
Quality
47
Growth
100
Enliven Therapeutics, Inc. (ELVN) trades at $48.80 on $3.59B of equity value, with a trailing P/E of -30.47. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.